利妥昔单抗联合治疗B细胞淋巴瘤患者的不良反应：通过嗜碱性粒细胞活化试验对利妥昔单抗超敏反应进行体外评估。 - Suppr

Suppr

超能文献

Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test.

作者信息

Piva Elisa, Chieco-Bianchi Fulvia, Krajcar Valentino, Aversa Savina, Plebani Mario

出版信息

Am J Hematol. 2012 Nov;87(11):E130-1. doi: 10.1002/ajh.23329. Epub 2012 Sep 17.

DOI:10.1002/ajh.23329

PMID:22987289

Abstract

摘要

相似文献

Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test.利妥昔单抗联合治疗B细胞淋巴瘤患者的不良反应：通过嗜碱性粒细胞活化试验对利妥昔单抗超敏反应进行体外评估。

Am J Hematol. 2012 Nov;87(11):E130-1. doi: 10.1002/ajh.23329. Epub 2012 Sep 17.

Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.利妥昔单抗治疗后 B 细胞淋巴瘤患者乙型肝炎表面抗体滴度分析。

Ann Hematol. 2012 Jul;91(7):1007-12. doi: 10.1007/s00277-012-1405-6. Epub 2012 Jan 25.

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.乙肝表面抗原阴性/乙肝核心抗体阳性患者接受利妥昔单抗联合化疗而未常规进行抗病毒预防时乙型肝炎病毒（HBV）再激活的风险。

Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.

Anti-CD20 antibody therapy for B-cell lymphomas.用于B细胞淋巴瘤的抗CD20抗体疗法。

N Engl J Med. 2012 May 24;366(21):2008-16. doi: 10.1056/NEJMct1114348.

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.基于利妥昔单抗和甲氨蝶呤的方案（GMALL B-ALL/NHL 2002 方案）在伯基特淋巴瘤和原发性纵隔大 B 细胞淋巴瘤中的疗效和毒性。

Am J Hematol. 2011 Dec;86(12):E61-4. doi: 10.1002/ajh.22165. Epub 2011 Sep 2.

HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.含利妥昔单抗方案治疗的 B 细胞非霍奇金淋巴瘤患者的 HCV 阳性状态和肝炎发作。

Dig Liver Dis. 2011 Feb;43(2):139-42. doi: 10.1016/j.dld.2010.05.010. Epub 2010 Jun 15.

VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: a multicenter experience.VNCOP-B 联合利妥昔单抗治疗老年侵袭性 B 细胞非霍奇金淋巴瘤：一项多中心经验。

Arch Gerontol Geriatr. 2010 Sep-Oct;51(2):209-15. doi: 10.1016/j.archger.2009.10.010. Epub 2009 Nov 18.

Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.盐酸苯达莫司汀联合利妥昔单抗治疗复发或难治性侵袭性 B 细胞非霍奇金淋巴瘤的可行性和药代动力学研究。

Cancer Sci. 2011 Sep;102(9):1687-92. doi: 10.1111/j.1349-7006.2011.01994.x. Epub 2011 Jul 7.

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.利妥昔单抗联合 CODOX-M/IVAC：23 例非 HIV 相关 B 细胞非霍奇金淋巴瘤增殖指数>95%的回顾性分析。

Br J Haematol. 2011 Jan;152(2):175-81. doi: 10.1111/j.1365-2141.2010.08447.x. Epub 2010 Nov 24.

The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome.通过流式细胞术测定阿司匹林和其他非甾体抗炎药（NSAIDs）诱导的嗜碱性粒细胞活化，有助于非甾体抗炎药超敏反应综合征的体外诊断。

Clin Exp Allergy. 2004 Sep;34(9):1448-57. doi: 10.1111/j.1365-2222.2004.02050.x.

引用本文的文献

Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper.嗜碱性粒细胞活化试验：在过敏肿瘤学中为诊断、治疗和预后应用搭建过敏与肿瘤学之间的桥梁：一篇欧洲变态反应和临床免疫学会立场文件

Allergy. 2025 Aug;80(8):2097-2112. doi: 10.1111/all.16607. Epub 2025 Jun 12.

Utilizing Biologics in Drug Desensitization.利用生物制剂进行药物脱敏。

Curr Allergy Asthma Rep. 2023 Jan;23(1):1-11. doi: 10.1007/s11882-022-01052-z. Epub 2022 Nov 29.

Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.实用静脉内快速药物脱敏和去标签标准：WAO委员会声明

World Allergy Organ J. 2022 May 31;15(6):100640. doi: 10.1016/j.waojou.2022.100640. eCollection 2022 Jun.

Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia.B细胞肿瘤患者中利妥昔单抗确诊临床超敏反应的评估

Adv Hematol. 2020 Jun 11;2020:4231561. doi: 10.1155/2020/4231561. eCollection 2020.

Hypersensitivity Reactions to Monoclonal Antibodies in Children.儿童对单克隆抗体的过敏反应。

Medicina (Kaunas). 2020 May 12;56(5):232. doi: 10.3390/medicina56050232.

BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice?BAT 在药物过敏诊断中的应用：临床日常实践中的新工具？

Curr Allergy Asthma Rep. 2019 Mar 11;19(4):20. doi: 10.1007/s11882-019-0852-8.

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.嗜碱性粒细胞反应性作为速发型药物超敏反应生物标志物的潜力与局限性

Front Pharmacol. 2016 Jun 17;7:171. doi: 10.3389/fphar.2016.00171. eCollection 2016.

A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils.一种预测西妥昔单抗诱导的超敏反应的新方法：检测嗜碱性粒细胞上的药物特异性IgE

Cancer Med. 2016 Jun;5(6):1004-12. doi: 10.1002/cam4.658. Epub 2016 Feb 16.

Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.化疗和单克隆抗体脱敏：适应证和结局。

Curr Allergy Asthma Rep. 2014 Aug;14(8):453. doi: 10.1007/s11882-014-0453-5.

Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity.嗜碱性粒细胞活化试验在药物超敏反应诊断中的近期应用

Asia Pac Allergy. 2013 Oct;3(4):266-80. doi: 10.5415/apallergy.2013.3.4.266. Epub 2013 Oct 31.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验